Morrisville-based Sicel Technologies (www.siceltech.com), a privately held developer and manufacturer of implantable sensors and surface dosimeters has raised $7 million in convertible debt. The company focuses on developing pioneering implantable products targeted at improving delivery of cancer treatments.
Sicel, which employs around 30 people, focuses on developing pioneering implantable products targeted at improving delivery of cancer treatments. The company’s sensors are designed to offer physicians a way of obtaining real time feedback about the biological and physiological changes in patients’ cell and organ systems.
Sicel Technologies is a CED member.